Taina Turpeenniemi‐Hujanen

Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer

Heikki Joensuu, Pirkko‐Liisa Kellokumpu‐Lehtinen, Petri Bono et al. · New England Journal of Medicine · 2006 · 1.4K citations

Medicine, Oncology, Pharmacology +16

Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial

Heikki Joensuu, Petri Bono, Vesa Kataja et al. · Journal of Clinical Oncology · 2009 · 459 citations · Full text

Medicine, Oncology, Pharmacology +17

NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice.

Unnur P. Thorgeirsson, Taina Turpeenniemi‐Hujanen, Jeannette E. Williams et al. · Molecular and Cellular Biology · 1985 · 240 citations · Full text

Medicine, Cancer Biology, Oncology +16

Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study

Harri Sihto, Johan Lundin, Mikael Lundin et al. · Breast Cancer Research · 2011 · 228 citations · Full text

Medicine, Oncology, Pathology +17

Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma

Anne Talvensaari‐Mattila, Paavo Pääkkö, Taina Turpeenniemi‐Hujanen · British Journal of Cancer · 2003 · 220 citations · Full text

Medicine, Oncology, Pathology +14